Policy Issues in the Development and Adoption of Biomarkers for Molecularly Targeted Cancer Therapies View on Open Library

Policy Issues in the Development and Adoption of Biomarkers for Molecularly Targeted Cancer Therapies

by Sharyl J. Nass , Jonathan Phillips , Margie Patlak , National Cancer Policy Forum , Board on Health Care Services

No reviews yet
First published: 2015 1 language ISBN: 9780309368605
Subjects
Cancer, treatment Cancer, genetic aspects Biochemical markers Cancer Treatment Genetic aspects

Reviews

Log in or sign up to write a review.

No reviews yet. Be the first!

More by Sharyl J. Nass

Multi-center phase III clinical trials and NCI cooperative groups

Multi-center phase III clinical trials a...

Applying Big Data to Address the Social Determinants of Health in Oncology

Applying Big Data to Address the Social ...

Patient-Centered Cancer Treatment Planning : Improving the Quality of Oncology Care

Patient-Centered Cancer Treatment Planni...

Role of Obesity in Cancer Survival and Recurrence

Role of Obesity in Cancer Survival and R...

Making Medicines Affordable

Making Medicines Affordable

Role of Clinical Studies for Pets with Naturally Occurring Tumors in Translational Cancer Research

Role of Clinical Studies for Pets with N...

You Might Also Like

More in Cancer, treatment
Clinical ophthalmic oncology

Clinical ophthalmic oncology

Arun D. Singh
The Spare Room

The Spare Room

Helen Garner
Horizons in Cancer Research

Horizons in Cancer Research

Hiroto S. Watanabe
Treatment of Cancer

Treatment of Cancer

Pat Price
Cancer medicine

Cancer medicine

James F. Holland
El mundo amarillo

El mundo amarillo

Albert Espinosa